Telefonaktiebolaget LM Ericsson (publ) (ERCB)
Deutsche Börse Xetra · Germany · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 9.950 |
|---|---|
| 52-week range | 7.900 – 11.810 |
| Return, 1 month / 3 months | +20.3% / +20.1% |
| Return, 1 year / 3 years | +25.6% / +165.1% |
| Trend | Uptrend |
| RSI (14) | 73 |
| Volatility (1 year) | 33.1% |
| Worst drawdown (1 year) | -30.1% |
| Average daily value traded | 0.03M EUR |
| Dividend yield | 0.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Ericsson is a Swedish telecommunications company that supplies mobile network operators with the equipment and software used to run cellular networks. Its products include radio base stations, antennas and core network systems, along with software for managing and operating networks. The company also provides related services such as network deployment, support and managed operations. It serves telecom operators and other network customers around the world, and its headquarters are in Stockholm, Sweden.
On this site Telefonaktiebolaget LM Ericsson (publ) appears as a stock on the Deutsche Börse Xetra (Germany), code ERCB, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Telefonaktiebolaget LM Ericsson (publ) (ERCB) trades on the Deutsche Börse Xetra in Germany. It last closed at EUR 9.950 on 27 October 2026.
Its price-based Market X-Ray is 52 out of 100 (a fair price profile), ranking 361 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 25.6% and over the last three months it rose 20.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Deutsche Börse Xetra
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 53 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 6.8% | ||
| From 52-week high | -15.4% | ||
| Momentum | 69 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 20.1% | ||
| 6-month return | 5.5% | ||
| 12-month return, skipping the last month | 4.4% | ||
| Stability (higher is calmer) | 56 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 33.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -30.1% | ||
| Liquidity | 32 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.03M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 26 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.2% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | +5.7% |
|---|---|
| 1 month | +20.3% |
| 3 months | +20.1% |
| 6 months | +5.5% |
| 1 year | +25.6% |
| 3 years | +165.1% |
| 5 years | +26.1% |
Signals
| 50-day / 200-day average | 8.666 / 9.313 |
|---|---|
| Golden / death cross (60 days) | Death, 50 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.219 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 28 Sep 2026 | SEK 0.1324 |
| 1 Apr 2026 | SEK 0.1378 |
| 26 Sep 2025 | SEK 0.1288 |
| 26 Mar 2025 | SEK 0.1322 |
| 1 Oct 2024 | SEK 0.1188 |
| 4 Apr 2024 | SEK 0.1175 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Deutsche Börse Xetra; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.